04:17 PM EDT, 06/20/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on June 17, 2024, sold 11,950 shares in Revolution Medicines ( RVMD ) for $446,770. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 838,337 shares of the company, with 311,885 shares held directly and 526,452 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071724000352/xslF345X03/form4.xml